The stock market accelerated on Wednesday as President Donald Trump announced a 90-day pause on some of his tariffs. According to Treasury Secretary Scott Bessent, all countries (excluding China) would return to the 10% baseline tariff rate as negotiations take place. This, however, does not apply to sector tariffs.
Overall, S&P 500 recorded its best day since 2008, jumping 9.5% to 5,457. Meanwhile, NASDAQ surged to its highest gain in a day since 2001, surging 12.2% to 17,125.
Tweet of the Day
My list includes: $SE $RBRK and $TGTX https://t.co/L3q11fErX4
— David Sharek (@GrowthStockGuy) April 8, 2025
Chart of the Day
Here is the one-year chart of Clearwater Analytics (CWAN) as of March 17, 2025, when the stock was at $27.
Clearwater Analytics is taking a bold step into the future with its strategic acquisition of Enfusion. Enfusion is a cloud-based investment management software provider that offers integrated front, middle, and back-office solutions, including portfolio management, order execution, analytics, and accounting, serving institutional investors and hedge funds. Both Clearwater Analytics and Enfusion share a strong multi-year track record powered by next-generation platforms designed for a complex landscape.
However, each company had a unique strength. Enfusion provides a best-in-class front office, providing top-tier portfolio and order management systems, while Clearwater Analytics is a leader in the middle and back office, excelling in investment accounting, compliance, and reporting.
CWAN is on the radar of our Growth Portfolio.
